Abstract
The irreversible inhibition of acetylcholinesterase (AChE) by organophosphorous chemical warfare agents necessitates that antidotes be administered for effective treatment. Currently no antidote is known that resurrects the phosphyl-AChE complex once aging has occurred. This report characterizes the affinities of over 30 new AChE inhibitors which could act as resurrecting agents for the aged AChE-OP adduct.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 5786-5789 |
| Number of pages | 4 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 23 |
| Issue number | 21 |
| DOIs | |
| State | Published - Nov 1 2013 |
Bibliographical note
Funding Information:This work was supported by the CounterACT Program, National Institutes of Health Office of the Director, and the National Institute of Neurological Disorders and Stroke, Grant 5 R21 NS076430. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Keywords
- 2-Methoxypyridinium compounds
- Acetylcholinesterase
- Reversible inhibition
Fingerprint
Dive into the research topics of 'Reversible inhibition of human acetylcholinesterase by methoxypyridinium species'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS